Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor immediately if any of the following side effects occur while taking hydroxychloroquine: Incidence not known Some side effects of hydroxychloroquine may occur that usually do not need medical attention. Chloroquine side effects anxiety Plaquenil safe to take Chloroquine treatment Find information about common, infrequent and rare side effects of Plaquenil Oral. If any severe blood disorder such as aplastic anemia, agranulocytosis, leukopenia, or thrombocytopenia, appears which is not attributable to the disease under treatment, consider discontinuation of Plaquenil. Plaquenil should be administered with caution in patients having glucose-6-phosphate dehydrogenase G-6-PD deficiency. PDR Drug Summaries are concise point-of-care prescribing, dosing and administering information to help phsyicans more efficiently and accurately prescribe in their practice PDR's drug summaries are available free of charge and serve as a great resource for US based MDs, DOs, NPs and PAs in patient practice Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. These side effects may go away during treatment as your body adjusts to the medicine. Plaquenil and thrombocytopenia Plaquenil What You Need to Know - Kaleidoscope Fighting Lupus, Plaquenil - FDA prescribing information, side effects and uses Eye tests required for plaquenilUlcer plaquenilHydroxychloroquine withdrawal Thrombocytopenia is found among people who take Plaquenil, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years, also take medication Enbrel, and have High blood pressure Will you have Thrombocytopenia with Plaquenil - eHealthMe. Plaquenil hydroxychloroquine sulfate dose, indications.. Long-Term Side Effects of Plaquenil for Rheumatoid.. Keywords Immune thrombocytopenia, Plaquenil®, Platelets, Prednisone, T regulatory cells, Vitamin D. Introduction. Immune thrombocytopenic purpura ITP is thought to be an autoimmune disorder mediated by autoantibodies with no known etiology, and the incidence is approximately 2.5 per 100,000 persons per year. The aim of the study was to examine the clinical characteristics and prognosis according to severity of thrombocytopenia and response to treatment for thrombocytopenia in patients with systemic lupus erythematosus SLEretrospectively evaluated 230. Thrombocytopenia is a common problem occurring in patients and drug-induced thrombocytopenia is a significant cause of present an unusual case of thrombocytopenia that was considered to be associated with the use of hydroxychloroquine.